|
|
 |
 |
| |
|
|
|
|
 |
| |
 |
|
Cravit® is a synthetic antibacterial agent containing
levofloxacin, a broad-spectrum fluoroquinolone effective against a wide range
of Gram-positive and Gram-negative pathogens. It is indicated for acute
maxillary sinusitis, acute exacerbation of chronic bronchitis,
community-acquired pneumonia, uncomplicated skin and skin-structure infections,
complicated urinary tract infections, and acute pyelonephritis. Cravit i.v. 500
mg is a ready-to-use solution containing 500 mg of levofloxacin/100 mL. It
should be administered intravenously by slow infusion over a period of not less
than 60 minutes every 24 hours.
Detailed Product Information >>  |
|
|
|
 |
|
An oral quinolone preparation with 99% bioavailability
containing levofloxacin, with a two-fold stronger activity than ofloxacin and
antibacterial activity against a wide range of Gram-positive and Gram-negative
bacteria. The adult daily dosage can be given from 200 mg to 600 mg in 2 or 3
divided doses.
Detailed Product Information >>
|
|
|
|
 |
|
Cravit® is a synthetic antibacterial agent containing
levofloxacin, a broad-spectrum fluoroquinolone effective against a wide range
of Gram-positive and Gram-negative pathogens. It is indicated for acute
maxillary sinusitis, acute exacerbation of chronic bronchitis,
community-acquired pneumonia, uncomplicated skin and skin-structure infections,
complicated urinary tract infections, and acute pyelonephritis. Each
film-coated Cravit® tablet contains 250 mg or 500 mg of levofloxacin. The
recommended oral dosage is one tablet every 24 hours.
Detailed Product Information >>
|
| |
|
 |
|
|
|
 |
 |
|
An oral quinolone preparation containing ofloxacin, an
antibacterial agent with a broad-spectrum activity against various
Gram-positive and Gram-negative bacteria. The adult daily dose is 300 mg to 600
mg in 2 or 3 divided doses. Tarivid Tablets are available in 100 mg and 200 mg
units.
Detailed Product Information >>
|
|
|
|
 |
|
A quinolone ear solution containing ofloxacin (0.3%, 3 mg/mL), a
broad-spectrum antibacterial agent indicated for Gram-positive and
Gram-negative otitis media and otitis externa. The adult dose is 6-10 drops
twice daily.
Detailed Product Information >>
|
| |
|
|
|
|
|
 |
 |
|
An IV preparation of tranexamic acid (5% or 10% w/v solution)
indicated in haemorrhagic, allergic and inflammatory conditions involving
hyperfibrinolysis, such as abnormal bleeding in surgery, O&G, urology, or
erythema. The adult daily dosage is 250-500 mg in 1-2 injections, or 500-2500
mg by IV drip infusion during and after surgery.
Detailed Product Information >>
|
|
|
|
 |
|
An oral preparation of tranexamic acid (250 mg/cap), indicated
in haemorrhagic, allergic and inflammatory conditions involving
hyperfibrinolysis, such as abnormal bleeding in surgery, O&G, urology, or
erythema. The adult daily dosage is 3-8 capsules in 3 or 4 portions.
Detailed Product Information >>
|
| |
|
|
|
| |
 |
|
|
|
|
